Brain Research Bulletin · Nov 17, 2026

Alleviation of Cuproptosis Contributes to the Reduction of Early Brain Injury by Mitophagy after Subarachnoid Hemorrhage

By Luo P, Kuang Y, Fan H et al.

BACKGROUND: The role of cuproptosis, a novel mitochondrial-dependent cell death, in early brain injury (EBI) after subarachnoid hemorrhage (SAH) remains unknown. We investigated whether cuproptosis drives EBI and how it is regulated by mitophagy. METHODS: Using in vivo and in vitro SAH models, we analyzed cuproptosis markers (DLAT, FDX1), copper transporters (SLC31A1, ATP7B), and the therapeutic effects of copper chelation (tetrathiomolybdate, TTM) and rapamycin-induced mitophagy (verified via chloroquine blockade). RESULTS: SAH induced neuronal cuproptosis-associated features, characterized by SLC31A1/ATP7B-mediated copper overload and pathognomonic DLAT aggregation, while TTM treatment significantly ameliorated EBI. While SAH partially activated endogenous PINK1-Parkin mitophagy, this response was insufficient to halt mitochondrial collapse. Notably, Rapamycin enhanced both canonical (PINK1-Parkin) and non-canonical (Nix, FUNDC1) mitophagy pathways. This dual activation promoted the clearance of toxic DLAT aggregates, alleviated intracellular copper accumulation alongside reduced SLC31A1 expression, and restored mitochondrial membrane potential. Consequently, Rapamycin treatment reduced brain edema and improved neurological scores; however, intercepting mitophagic flux with chloroquine reversed its anti-cuproptotic effects. CONCLUSIONS: Cuproptosis-associated pathology is an important pathological driver of EBI following SAH. Pharmacological enhancement of mitophagic clearance via Rapamycin offers a promising strategy to mitigate neuronal damage at least in part by alleviating copper-induced proteotoxicity.

doi.org/10.1016/j.brainresbull.2026.112227PubMed 43044682Interventions

AgingResearch.News